This is the case in familial hypercholesterolemia (FH), an inherited metabolic disorder characterized by remarkably high levels of low-density lipoprotein cholesterol (LDL-C) due to genetic mutations that reduce the number or impair the function of the LDL receptors on the surface of hepatocytes. This evidence concerns the gene LDLR and familial hyperaldosteronism.